Eurofins Scientific (OTCMKTS:ERFSF) Sets New 1-Year Low at $76.62

Eurofins Scientific SE (OTCMKTS:ERFSFGet Rating) shares hit a new 52-week low during trading on Tuesday . The stock traded as low as $76.62 and last traded at $78.43, with a volume of 230 shares changing hands. The stock had previously closed at $79.45.

Several brokerages have recently commented on ERFSF. HSBC upgraded Eurofins Scientific from a “reduce” rating to a “hold” rating in a report on Friday, April 8th. Berenberg Bank raised Eurofins Scientific from a “hold” rating to a “buy” rating in a research report on Thursday, February 24th. Barclays cut their target price on Eurofins Scientific from €125.00 ($131.58) to €105.00 ($110.53) in a research report on Thursday, February 24th. Credit Suisse Group cut their target price on Eurofins Scientific from €125.00 ($131.58) to €110.00 ($115.79) and set an “outperform” rating on the stock in a research report on Thursday, February 24th. Finally, Societe Generale downgraded Eurofins Scientific from a “buy” rating to a “hold” rating in a research report on Friday, June 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $105.00.

The firm has a 50-day simple moving average of $90.19 and a two-hundred day simple moving average of $100.15. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.17 and a current ratio of 1.25.

About Eurofins Scientific (OTCMKTS:ERFSF)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Recommended Stories

Receive News & Ratings for Eurofins Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scientific and related companies with MarketBeat.com's FREE daily email newsletter.